|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Bad debt expense | |||||
| Non-cash impairment charges related to lease abandonment | |||||
| Accretion of investments | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other assets | |||||
| Operating lease right-of-use assets | |||||
| Accounts payable | |||||
| Operating lease liabilities | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Sales of marketable securities | |||||
| Maturities of marketable securities | |||||
| Loan to Opportunity Finance Network | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock upon exercise of stock options | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Payment of transaction costs related to the reverse recapitalization | |||||
| Tax withholdings on release of restricted stock units | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental cash flow disclosures | |||||
| Cash paid for taxes | |||||
| Non-cash investing and financing activities: | |||||
| Vesting of restricted stock and early exercised stock options | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
| Unpaid deferred transaction costs | |||||
| Conversion of redeemable convertible preferred stock into Class B common stock in connection with the Reverse Recapitalization | |||||
| Remeasurement of operating lease liability and right-of-use asset | |||||
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash, non-current | |||||
Loading...